HALO
Chart
Ratings & dials
1m · 5m · 15m · 1h · 4h · 1DAnalyst & Morningstar ratings
Consensus · Targets · MorningstarThird-party ratings, not SURVYR.'s views.
Key stats & company
What they do
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules.
Valuation and fundamentals
Valuation & fundamentals
For information only · Important disclosures
Grades vs sector
Momentum86th percentile in sectorA-
Percentile within its GICS sector across the S&P 1500.
Growth94th percentile in sectorA
Percentile within its GICS sector across the S&P 1500.
Value68th percentile in sectorB
Percentile within its GICS sector across the S&P 1500.
Profitability93rd percentile in sectorA
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Systematic Models
Not held by any of our 7 live models right now.
Earnings & events
HALO earningsNext report in 8 daysIn line = within 1% of the estimate.
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $481.0M | +47.7% |
| 2026-03-31 | $376.7M | – |
| 2025-12-31 | $451.8M | – |
| 2025-09-30 | $354.3M | – |
| 2025-06-30 | $325.7M | – |
News & catalysts
More newsRating changes
Third-party analyst actions, not SURVYR.'s views. All rating changes
Stats refreshed 2026-10-25 10:18:13 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Get the market emails
Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdaysIndexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.
Check your inbox to confirm
We sent a link to . Tap it to start your emails. Nothing is sent until you confirm.
Not there in a minute? Check spam, or .
Dev mode No email provider here, so the confirm link is shown: Open confirm link
Free to use. No card, no ads, no auto-renew.
Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Coteau 0.9 · Oct 21, 2026